Wize Pharma Stock

Wize Pharma Acquisitions (Net)

Delisted·Jan 10, 2019

The Acquisitions (Net) of Wize Pharma (WIZP) as of Aug 18, 2026 is 824,000.00 USD.

Acquisitions (Net)

824,000.00USD

Last updated:

Acquisitions (Net) of Wize Pharma is 2026 824,000.00 USD. Acquisitions (Net) of Wize Pharma was 2025 0.00 USD. It decreases by % higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Wize Pharma Stock analysis

What does Wize Pharma do? Wize Pharma Inc. is a leading biopharmaceutical company specializing in the development and marketing of innovative products for the treatment of eye diseases. The company was founded in 1997 and is headquartered in Herzliya Pituach, Israel. It focuses on the research, development, manufacturing, and marketing of eye disease treatments. The company aims to become a leading brand in the field of eye health and offers high-quality services in eye care. Wize Pharma Inc. operates different divisions, with its main divisions being the development and marketing of eye therapeutics, including LO2A and LO2B. LO2A is an innovative therapy for dry eye, while LO2B is an intraoperative formulation used in glaucoma surgery. The company's products provide effective and sustainable solutions for the treatment of eye diseases. Wize Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wize Pharma stock

Acquisitions (Net) of Wize Pharma is 824,000.00 USD in 2026.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Wize Pharma since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Wize Pharma historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Cash Flow — Wize Pharma

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Wize Pharma